Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial

May 21, 2026

More like this

August 13, 2026

Remepy raises US$36m to advance Parkinson’s treatment into Phase III

Health Tech World

August 12, 2026

Remepy Raises $36 Million Series A To Advance Hybridopa Phase III And Hybrid Drug Pipeline

Pulse 2.0

August 13, 2026

Remepy Raises $36M to Advance Hybrid Drugs Into Phase II

Tech Lens Media